← Leaderboards
Mark N Kirstein
University Of Minnesota
$430,149
Attributed
$430,149
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $76.1K · FY2007–23$100K$75K$50K$25K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$430,149 · 4
By mechanism
P30$380,420 · 1
M01$49,729 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Douglas Yee$35,505,227
- Robert J. Turesky$19,878,824
- David J Odde$19,147,767
- Melanie Rae Nicol$2,326,366
- Brenda J. Weigel$37,619,294
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantPharmacogeneticsResearch PersonnelDrug KineticsResourcesBlood SpecimenBiological AvailabilityAnticancer ResearchCancer TherapyCancer Clinical TrialClia CertifiedClinical Cancer CenterClinical InvestigatorClinical PharmacologyAssay DevelopmentAnimal Cancer ModelCancer Center Support GrantDrug InteractionsCost EfficientDesignDoctor Of PharmacyDoseDrug DevelopmentCollege
Grant awards (8)
Clinical Pharmacology Shared Resource$76,084
P30 · FY2023 · CA · contact PI
Clinical Pharmacology Shared Resource$76,084
P30 · FY2022 · CA · contact PI
Clinical Pharmacology Shared Resource$76,084
P30 · FY2021 · CA · contact PI
Clinical Pharmacology Shared Resource$76,084
P30 · FY2020 · CA · contact PI
Clinical Pharmacology Shared Resource$76,084
P30 · FY2019 · CA · contact PI
POPULATION PHARMACOKINETICS AND PHARMACOGENETICS OF GEMCITABINE IN ADULT PATIENT$15,368
M01 · FY2009 · RR · contact PI
POPULATION PHARMACOKINETICS AND PHARMACOGENETICS OF GEMCITABINE IN ADULT PATIENT$21,643
M01 · FY2008 · RR · contact PI
POPULATION PHARMACOKINETICS AND PHARMACOGENETICS OF GEMCITABINE IN ADULT PATIENT$12,718
M01 · FY2007 · RR · contact PI